In this context, MDSCs have been reported to activate the AKT and ERK pathways, facilitated by the overexpression of chemokines such as CCL11, which further promote invasion, EMT, and metastasis in NSCLC [508]. Here, AKT1 is linked to non-small cell lung carcinoma.